FDA approves new nasal spray to reverse opioid overdoses.

TL;DR Summary
The FDA has approved Opvee, a nasal-spray medication that can reverse overdoses caused by synthetic opioids, including fentanyl. However, some public health experts, physicians, and community groups are concerned about the cost and potential side effects of the drug. Opvee is a more potent medication than naloxone, which is widely used to reverse overdoses, and may cause agonizing, long-lasting withdrawal symptoms for some drug users after they are revived. Critics argue that cheaper, proven medications such as naloxone are sufficient to combat overdose deaths.
- New overdose antidote approved, but concerns raised about cost, side effects The Washington Post
- A new nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval NPR
- US FDA approves Opiant's spray for reversing opioid-related overdoses Reuters
- Analysis | A new opioid overdose antidote to enter the market The Washington Post
- New nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval in U.S. CP24
Reading Insights
Total Reads
0
Unique Readers
10
Time Saved
6 min
vs 7 min read
Condensed
93%
1,239 → 84 words
Want the full story? Read the original article
Read on The Washington Post